Accelerating Science: How to cure the incurable with cell and gene therapy

Explore the InSphero MASH CALL initiative
3 November 2023

In this application note, explore the InSphero MASH CALL initiative, a fast and cost-effective identification of drug candidates in MASH (Metabolic Dysfunction-associated Steatohepatitis, renamed from NASH). Furthermore, discover how the 3D InSight™ Liver Microtissue MASH model is a robust, reproducible and translational model that can recapitulate human hallmarks of MASH predictive of clinical candidates.


     Page  Next